Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
Thompson A, Lamberth E, Severs J, Scully I, Tarabar S, Ginis J, Jansen KU, Gruber WC, Scott DA, Watson W.
Thompson A, et al. Among authors: watson w.
Vaccine. 2019 Sep 30;37(42):6201-6207. doi: 10.1016/j.vaccine.2019.08.048. Epub 2019 Sep 5.
Vaccine. 2019.
PMID: 31495592
Clinical Trial.